메뉴 건너뛰기




Volumn 59, Issue 6, 2010, Pages 752-759

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: Efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE;

EID: 77953726380     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.194159     Document Type: Article
Times cited : (157)

References (37)
  • 1
    • 0033019865 scopus 로고    scopus 로고
    • Surgical therapy for ulcerative colitis and Crohn's disease
    • Becker JM. Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1999;28:371-90.
    • (1999) Gastroenterol Clin North Am , vol.28 , pp. 371-390
    • Becker, J.M.1
  • 3
    • 0036301471 scopus 로고    scopus 로고
    • Inflammatory bowel disease: Medical therapy of specific clinical presentations
    • DOI 10.1016/S0889-8553(01)00012-7, PII S0889855301000127
    • Banerjee S, Peppercorn MA. Inflammatory bowel disease: medical therapy of specific clinical presentations. Gastroenterol Clin North Am 2002;31:185-202. (Pubitemid 34733040)
    • (2002) Gastroenterology Clinics of North America , vol.31 , Issue.1 , pp. 185-202
    • Banerjee, S.1    Peppercorn, M.A.2
  • 5
    • 0028900762 scopus 로고
    • Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease
    • Italian Cooperative Study Group
    • Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology 1995;108:345-9.
    • (1995) Gastroenterology , vol.108 , pp. 345-349
    • Brignola, C.1    Cottone, M.2    Pera, A.3
  • 6
    • 0028264154 scopus 로고
    • Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease
    • Gruppo Italiano per lo Studio del Colon e del Retto (GISC)
    • Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 1994;8:35-43.
    • (1994) Aliment Pharmacol Ther , vol.8 , pp. 35-43
    • Caprilli, R.1    Andreoli, A.2    Capurso, L.3
  • 7
    • 9244235034 scopus 로고    scopus 로고
    • Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease
    • Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID)
    • Florent C, Cortot A, Quandale P, et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol 1996;8:229-33.
    • (1996) Eur J Gastroenterol Hepatol , vol.8 , pp. 229-233
    • Florent, C.1    Cortot, A.2    Quandale, P.3
  • 8
    • 0033965199 scopus 로고    scopus 로고
    • Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI
    • Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 2000;118:264-73.
    • (2000) Gastroenterology , vol.118 , pp. 264-273
    • Lochs, H.1    Mayer, M.2    Fleig, W.E.3
  • 9
    • 0029128340 scopus 로고
    • Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease
    • Mcleod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995;109:404-13.
    • (1995) Gastroenterology , vol.109 , pp. 404-413
    • Mcleod, R.S.1    Wolff, B.G.2    Steinhart, A.H.3
  • 10
    • 0041395773 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease
    • Sutherland LR, Martin F, Bailey RJ, et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. Gastroenterology 1997;112:1069-77.
    • (1997) Gastroenterology , vol.112 , pp. 1069-1077
    • Sutherland, L.R.1    Martin, F.2    Bailey, R.J.3
  • 11
    • 0030775667 scopus 로고    scopus 로고
    • Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables
    • Camma C, Giunta M, Rosselli M, et al. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997;113:1465-73.
    • (1997) Gastroenterology , vol.113 , pp. 1465-1473
    • Camma, C.1    Giunta, M.2    Rosselli, M.3
  • 12
    • 33144459948 scopus 로고    scopus 로고
    • European evidence based consensus on the diagnosis and management of Crohn's disease: Current management
    • Travis SPL, Stange EF, Lemann M, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006;55(Suppl 1):i16-35.
    • (2006) Gut , vol.55 , Issue.SUPPL. 1
    • Travis, S.P.L.1    Stange, E.F.2    Lemann, M.3
  • 13
    • 36349024564 scopus 로고    scopus 로고
    • Azathioprine for prevention of postoperative recurrence in Crohn's disease
    • Abdelli MN, Ben AH, Houissa F, et al. [Azathioprine for prevention of postoperative recurrence in Crohn's disease]. Tunis Med 2007;85:569-72.
    • (2007) Tunis Med , vol.85 , pp. 569-572
    • Abdelli, M.N.1    Ben, A.H.2    Houissa, F.3
  • 14
    • 33749037153 scopus 로고    scopus 로고
    • Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease
    • Myrelid P, Svarm S, Andersson P, et al. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease. Scand J Gastroenterol 2006;41:1190-5.
    • (2006) Scand J Gastroenterol , vol.41 , pp. 1190-1195
    • Myrelid, P.1    Svarm, S.2    Andersson, P.3
  • 15
    • 53249097726 scopus 로고    scopus 로고
    • Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: A controlled randomized trial
    • D'Haens GR, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 2008;135:1123-9.
    • (2008) Gastroenterology , vol.135 , pp. 1123-1129
    • D'Haens, G.R.1    Vermeire, S.2    Van Assche, G.3
  • 16
    • 4444353986 scopus 로고    scopus 로고
    • Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial
    • Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004;127:723-9.
    • (2004) Gastroenterology , vol.127 , pp. 723-729
    • Hanauer, S.B.1    Korelitz, B.I.2    Rutgeerts, P.3
  • 17
    • 4444366271 scopus 로고    scopus 로고
    • Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease
    • Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004;127:730-40.
    • (2004) Gastroenterology , vol.127 , pp. 730-740
    • Ardizzone, S.1    Maconi, G.2    Sampietro, G.M.3
  • 18
    • 73949083566 scopus 로고    scopus 로고
    • Endscopy and MR enteroclysis: Equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection
    • Koilakou S, Sailer J, Peloschek P, et al. Endscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Inflamm Bowel Dis 2010;16:198-203.
    • (2010) Inflamm Bowel Dis , vol.16 , pp. 198-203
    • Koilakou, S.1    Sailer, J.2    Peloschek, P.3
  • 19
    • 0017227303 scopus 로고
    • Development of a Crohn's disease activity index
    • National Cooperative Crohn's Disease Study
    • Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
    • (1976) Gastroenterology , vol.70 , pp. 439-444
    • Best, W.R.1    Becktel, J.M.2    Singleton, J.W.3
  • 20
    • 0028047268 scopus 로고
    • Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease
    • Canadian Crohn's Relapse Prevention Trial Study Group
    • Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994;106:287-96.
    • (1994) Gastroenterology , vol.106 , pp. 287-296
    • Irvine, E.J.1    Feagan, B.2    Rochon, J.3
  • 21
    • 33847153405 scopus 로고    scopus 로고
    • Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine
    • Dilger K, Schaeffeler E, Lukas M, et al. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Ther Drug Monit 2007;29:1-5.
    • (2007) Ther Drug Monit , vol.29 , pp. 1-5
    • Dilger, K.1    Schaeffeler, E.2    Lukas, M.3
  • 22
    • 3242762099 scopus 로고    scopus 로고
    • Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants
    • Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004;14:407-17.
    • (2004) Pharmacogenetics , vol.14 , pp. 407-417
    • Schaeffeler, E.1    Fischer, C.2    Brockmeier, D.3
  • 23
    • 0024356033 scopus 로고
    • Development and validation of an endoscopic index of the severity for Crohn's disease: A prospective multicentre study
    • Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)
    • Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989;30:983-9.
    • (1989) Gut , vol.30 , pp. 983-989
    • Mary, J.Y.1    Modigliani, R.2
  • 24
    • 70449596780 scopus 로고    scopus 로고
    • SONIC: A randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy
    • P087
    • Colombel JF, Rutgeerts P, Reinisch W, et al. SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy. J Crohn's and Colitis 2009;3:S45 (P087).
    • (2009) J Crohn's and Colitis , vol.3
    • Colombel, J.F.1    Rutgeerts, P.2    Reinisch, W.3
  • 25
    • 33749189358 scopus 로고    scopus 로고
    • Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease
    • AZT-1 Study Group
    • Herfarth H, Tjaden C, Lukas M, et al. AZT-1 Study Group. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease. Gut 2006;55:1525-6.
    • (2006) Gut , vol.55 , pp. 1525-1526
    • Herfarth, H.1    Tjaden, C.2    Lukas, M.3
  • 26
    • 68349137946 scopus 로고    scopus 로고
    • Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: A meta-analysis
    • Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol 2009;104:2089-96.
    • (2009) Am J Gastroenterol , vol.104 , pp. 2089-2096
    • Peyrin-Biroulet, L.1    Deltenre, P.2    Ardizzone, S.3
  • 27
    • 7044268960 scopus 로고    scopus 로고
    • Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases
    • Weersma RK, Peters FTM, Oostenbrug LE, et al. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases. Aliment Pharmacol Ther 2004;20:843-50.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 843-850
    • Weersma, R.K.1    Peters, F.T.M.2    Oostenbrug, L.E.3
  • 28
    • 77953692159 scopus 로고    scopus 로고
    • Anzathioprine
    • Thomson Reuters (Healthcare) Inc. Greenwood Village, Colorado, USA: Thomson Reuters (Healthcare)
    • Thomson Reuters (Healthcare) Inc. Anzathioprine. In: DRUGDEX® System [database on CD-ROM]. Greenwood Village, Colorado, USA: Thomson Reuters (Healthcare), 2010:143.
    • (2010) DRUGDEX® System [Database on CD-ROM] , pp. 143
  • 29
    • 0030048791 scopus 로고    scopus 로고
    • Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism
    • Szumlanski C, Otterness D, Her C, et al. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996;15:17-30.
    • (1996) DNA Cell Biol , vol.15 , pp. 17-30
    • Szumlanski, C.1    Otterness, D.2    Her, C.3
  • 30
    • 0029919807 scopus 로고    scopus 로고
    • Thiopurine S-methyltransferase deficiency: Two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians
    • Tai H-L, Krynetski EY, Yates CR, et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 1996;58:694-702.
    • (1996) Am J Hum Genet , vol.58 , pp. 694-702
    • Tai, H.-L.1    Krynetski, E.Y.2    Yates, C.R.3
  • 32
    • 1842788679 scopus 로고    scopus 로고
    • Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity
    • Nygaard U, Toft N, Schmiegelow K. Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity. Clin Pharmacol Ther 2004;75:274-81.
    • (2004) Clin Pharmacol Ther , vol.75 , pp. 274-281
    • Nygaard, U.1    Toft, N.2    Schmiegelow, K.3
  • 33
    • 33947287144 scopus 로고    scopus 로고
    • Thiopurine treatment in inflammatory bowel disease: Clinical pharmacology and implication of pharmacogenetically guided dosing
    • Teml A, Schaeffeler E, Herrlinger KR, et al. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharm 2007;46:187-208.
    • (2007) Clin Pharm , vol.46 , pp. 187-208
    • Teml, A.1    Schaeffeler, E.2    Herrlinger, K.R.3
  • 34
    • 48549088791 scopus 로고    scopus 로고
    • Transporter-mediated protection against thiopurine-induced hematopoietic toxicity
    • Krishnamurthy P, Schwab M, Takenaka K, et al. Transporter-mediated protection against thiopurine-induced hematopoietic toxicity. Cancer Res 2008;68:4983-9.
    • (2008) Cancer Res , vol.68 , pp. 4983-4989
    • Krishnamurthy, P.1    Schwab, M.2    Takenaka, K.3
  • 35
    • 58449117037 scopus 로고    scopus 로고
    • Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia
    • Stocco G, Cheok MH, Crews KR, et al. Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin Pharmacol Ther 2009;85:164-72.
    • (2009) Clin Pharmacol Ther , vol.85 , pp. 164-172
    • Stocco, G.1    Cheok, M.H.2    Crews, K.R.3
  • 36
    • 31144446293 scopus 로고    scopus 로고
    • Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression
    • Zelinkova Z, Derijks LJ, Stokkers PC, et al. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Clin Gastroenterol Hepatol 2006;4:44-9.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 44-49
    • Zelinkova, Z.1    Derijks, L.J.2    Stokkers, P.C.3
  • 37
    • 65449156896 scopus 로고    scopus 로고
    • Leukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine
    • van Asseldonk DP, Kanis BM, de Boer NK, et al. Leukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine. Digestion 2009;79:211-14.
    • (2009) Digestion , vol.79 , pp. 211-214
    • Van Asseldonk, D.P.1    Kanis, B.M.2    De Boer, N.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.